Medicare Enrolled
Dr. David Mizro, PA
Surgical Physician Assistant · Auburn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mizro from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mizro?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mizro
Dr. David Mizro is a surgical physician assistant in Auburn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mizro performed 4,869 Medicare services across 2,544 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mizro received a total of $1,975 from 20 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mizro is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NY
$1,975 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,869
Medicare services
Top 0% in NY for surgical physician assistant
2,544
Unique beneficiaries
$34
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,352 | $4 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
603 | $48 | $170 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
438 | $29 | $209 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
349 | $56 | $240 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
213 | $97 | $450 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
154 | $31 | $130 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
110 | $179 | $798 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
102 | $62 | $286 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
91 | $51 | $247 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
88 | $80 | $635 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $33 | $110 |
| Surgical removal of facial skin cancer, 1.1-2.0 cm This procedure involves the surgical excision of a cancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the removed tissue is between 1.1 and 2.0 centimeters. |
39 | $90 | $700 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 39 | $195 | $793 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring 1.1 to 2.0 centimeters from the scalp, neck, hands, feet, or genitals. |
30 | $83 | $658 |
| Intermediate wound repair, face or mouth, 2.5 cm or less A medical procedure to close a wound on the face, ears, eyelids, nose, lips, or mouth that is 2.5 centimeters or smaller. This type of repair involves more than simple closure but is less complex than a major repair. |
28 | $166 | $694 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
23 | $37 | $271 |
| Skin cancer removal, face or mouth area, 0.6-1.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters. |
22 | $78 | $611 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
21 | $56 | $310 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
20 | $73 | $451 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
19 | $148 | $628 |
| Skin tag removal, 1-15 tags This procedure involves the removal of one to fifteen skin tags. It is a minor surgical intervention to excise these benign growths from the skin. |
16 | $36 | $220 |
| Removal of noncancer skin growth, 1.1-2.0 cm This procedure involves the surgical removal of a benign skin growth located on the body, arms, or legs. The growth measured between 1.1 and 2.0 centimeters in diameter. |
16 | $56 | $417 |
| Intermediate wound repair, 2.6-7.5 cm This procedure involves stitching a wound on the neck, hands, feet, or genitals that measures between 2.6 and 7.5 centimeters. It is classified as an intermediate repair requiring layered closure. |
16 | $193 | $751 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
14 | $51 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,975
Total received (2021-2024)
Avg $494/year across 4 years
Top 12% in NY for surgical physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,843 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$132 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$602
2023
$577
2022
$426
2021
$371
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$132
Lilly USA, LLC
$104
ABBVIE INC.
$60
Novartis Pharmaceuticals Corporation
$40
Arcutis Biotherapeutics, Inc.
$37
SUN PHARMACEUTICAL INDUSTRIES INC.
$36
Regeneron Healthcare Solutions, Inc.
$36
UCB, Inc.
$34
Incyte Corporation
$23
Galderma Laboratories, L.P.
$18
PFIZER INC.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Amgen Inc.
$17
Dermavant Sciences, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 49.2% of 2024 payments
All-time payments by company (2021-2024) ›
Janssen Biotech, Inc.
$281
ABBVIE INC.
$238
Lilly USA, LLC
$199
Regeneron Healthcare Solutions, Inc.
$196
SUN PHARMACEUTICAL INDUSTRIES INC.
$156
GENZYME CORPORATION
$147
Sun Pharmaceutical Industries Inc.
$102
Amgen Inc.
$94
Novartis Pharmaceuticals Corporation
$87
Incyte Corporation
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$73
PFIZER INC.
$69
Arcutis Biotherapeutics, Inc.
$52
E.R. Squibb & Sons, L.L.C.
$51
Dermavant Sciences, Inc.
$47
UCB, Inc.
$34
LEO Pharma Inc.
$19
Galderma Laboratories, L.P.
$18
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
AbbVie Inc.
$12
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
ADBRY · Bimzelx · COSENTYX · CYLTEZO · DUPIXENT · EUCRISA · HUMIRA · ILUMYA · Ilumya · LIBTAYO · OLUMIANT · OPZELURA · Otezla · REMICADE · RINVOQ · SILIQ · SKYRIZI · SPEVIGO · Sotyktu · TALTZ · TREMFYA · VTAMA · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Surgical physician assistants within 10 mi
78
Per 100K population
103.4
County median income
$66,583
Nearest hospital
AUBURN COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mizro is a clinical cardiology specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement in the top 12% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mizro experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Mizro performed 2,352 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mizro receive payments from pharmaceutical companies?
Yes. Dr. Mizro received a total of $1,975 from 20 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mizro's costs compare to other surgical physician assistants in Auburn?
Dr. Mizro's average Medicare payment per service is $34. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mizro) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgical Physician Assistants in Auburn
Browse surgical physician assistants in Auburn ranked by procedure volume and transparency data.
Highest volume
Top Surgical Physician Assistants in NY
Surgical physician assistants ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgical Physician Assistants in NY
Which NY surgical physician assistants receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology